Association between reduced pulmonary diffusing capacity and cardiac autonomic dysfunction in Type 1 diabetes

Diabetic Medicine

Volumn 25, Issue 11, 2008, Pages 1366-1369

  Pitocco, D ^a   Santangeli, P ^a   Fuso, L ^a   Zaccardi, F ^a   Longobardi, A ^a   Infusino, F ^a   Incalzi, R A ^a   Lanza, G A ^a   Crea, F ^a   Ghirlanda, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autonomic neuropathy; DLCO; HRV; Type 1 diabetes

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HOLTER MONITORING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUNG BLOOD FLOW; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE;

AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS;

EID: 55149118004     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02571.x     Document Type: Article

References (24)

1. Vinik AL, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003 26 : 1553 1579.
2. Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 1999 7 : 300 315.
3. Malik RA. The pathology of human diabetic neuropathy. Diabetes 1997 46 : S50 S53.
4. Hsia CV, Raskin P. The diabetic lung: relevance of microangiopathy for the use of inhaled insulin. Am J Med 2005 118 : 205 211.
5. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillarroes: quantitative changes with ageing in diabetes mellitus. Am Rev Resp Dis 1979 120 : 973 983.
6. Nunn JF. Nunn' s Applied Respiratory Physiology. 4th edn. Oxford : Butterworth-Heinemann. 2000 193 : 198 218.
7. Antonelli Incalzi R, Fuso L, Pitocco D, Basso S, Trové A, Longobardi A et al. Decline of neuroadrenergic bronchial innervation and respiratory function in Type 1 diabetes mellitus: a longitudinal study. Diabetes Met Res Rev 2007 23 : 311 316.
8. Di Carli MF, Bianco-Batlles D, Landa ME, Katzmers A, Groehn H, Muzik O et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999 100 : 813 819.
9. American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care 2005 28 : S37 S42.
10. Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD. EURODIAB Prospective Complications Study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in Type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003 26 : 2165 2173.
11. Amin R, Turner C, van Aken S, Bahu TK, Watts A, Lindsell DR et al. The relationship between microalbuminuria and glomerular filtration rate in young Type 1 diabetic subjects: the Oxford regional prospective study. Kidney Int 2005 68 : 1740 1749.
12. Lanza GA. The electrocardiogram as a prognostic tool for predicting major cardiac events. Prog Cardiovasc Dis 2007 50 : 87 111.
13. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995 152 : 1107 1136.
14. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. 1995 update. Am J Respir Crit Care Med 1995 152 : 2185 2198.
15. Fuso L, Cotroneo P, Basso S, De Rosa M, Manto A, Ghirlanda G et al. Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest 1996 110 : 1009 1013.
16. Quanjer PH. Standardized lung function testing. Report Working Party. Standardization of lung function tests. European community for coal and steel. Bull Eur Physiopathol Respir 1983 19 : S1 82.
17. Ljubić S, Metelko Z, Car N, Roglić G, Drazić Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998 114 : 1033 1035.
18. Meerwaldt R, Links TP, Graaf R, Hoogenberg K, Lefrandt JD, Baynes JW et al. Increased accumulation of skin advanced glycation end products precedes and correlates with clinical manifestation of diabetes neuropathy. Diabetologia 2005 48 : 1637 1644.
19. Schleicher E, Wagner E, Nerlich AG. Increased accumulation of glycoxidation product Ne-lysine in human tissues in diabetes and ageing J Clin Inv 1997 9 : 457 468.
20. Cameron NE, Cotter MA, Dines K, Love A. Effect of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin- diabetic rats. Diabetologia 1992 35 : 946 950.
21. Antonelli Incalzi R, Fuso L, Giordano A, Pitocco D. Neuroadrenergic denervation of the lung in Type 1 diabetes complicated by autonomic neuropathy. Chest 2002 121 : 443 451.
22. Brownlee M, Vlassara H, Cerami A. Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984 101 : 527 537.
23. Antonelli Incalzi R, Fuso L, Pitocco D. Inhaled insulin and the lung. Curr Med Chem 2007 14 : 1335 1347.
24. NICE. Inhaled Insulin for the Treatment of Diabetes (Types 1 and 2). London : National Institute for Clinical Excellence, 2006. Available at http://www.nice.org.uk/TA113 Last accessed 22 March 2008.